Teh, J. L., Erkes, D. A., Cheng, P. F., Tiago, M., Wilski, N. A., Field, C. O., . . . Aplin, A. E. (2020). Activation of CD8(+) T cells contributes to antitumor effects of CDK4/6 inhibitors plus MEK inhibitors. Cancer Immunol Res.
استشهاد بنمط شيكاغوTeh, Jessica L.F., et al. "Activation of CD8(+) T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors Plus MEK Inhibitors." Cancer Immunol Res 2020.
MLA استشهادTeh, Jessica L.F., et al. "Activation of CD8(+) T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors Plus MEK Inhibitors." Cancer Immunol Res 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.